Gene expression in tissue associated with extracellular matrix modified ePTFE

Journal of Biomedical Materials Research - Part A

Volumn 73, Issue 1, 2005, Pages 30-38

  Schwartz, Mark A ^a   Stone, Alice L ^a   Greer, Kevin A ^a   Hoying, James B ^a   Williams, Stuart K ^a  

^a University of Arizona   (United States)

Author keywords

Biocompatibility; cDNA microarrays; ePTFE; Gene expression; Vascular response

Indexed keywords

BIOCOMPATIBILITY; BIOMEDICAL EQUIPMENT; GENES; GENETIC ENGINEERING; MOLECULES; POLYTETRAFLUOROETHYLENES;

GENE EXPRESSION; TISSUE HEALING; TRANSCRIPTIONAL ACTIVITY; VASCULARIZATION;

TISSUE;

COMPLEMENTARY DNA; POLITEF;

ANALYSIS OF VARIANCE; ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; DNA FINGERPRINTING; DNA MICROARRAY; EXTRACELLULAR MATRIX; GENE CLUSTER; GENE EXPRESSION; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; IMPLANTATION; INFLAMMATION; KERATINOCYTE; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; SURFACE PROPERTY; VASCULARIZATION;

ALPHA-FETOPROTEINS; ANIMALS; CELL LINE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MALE; MICE; MULTIGENE FAMILY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOBLASTS; POLYTETRAFLUOROETHYLENE; POROSITY; RNA, MESSENGER; WOUND HEALING;

EID: 14844363393     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.a.30228     Document Type: Article

References (23)

1. Anderson JM. Inflammatory response to implants. ASAIO Trans 1988;34:101-107.
2. Wisniewski N, Klitzman B, Miller B, Reichert WM. Decreased analyte transport through implanted membranes: differentiation of biofouling from tissue effects. J Biomed Mater Res 2001;57:513-521.
3. Tassiopoulos AK, Greisler HP. Angiogenic mechanisms of endothelialization of cardiovascular implants: a review of recent investigative strategies. J Biomater Sci Polym Ed 2000;11:1275-1284.
4. van Bilsen PH, Popa ER, Brouwer LA, Vincent J, Taylor CE, de Leij LF, Hendriks M, van Luyn MJ. Ongoing foreign body reaction to subcutaneous implanted (heparin) modified Dacron in rats. J Biomed Mater Res 2004;68A:423-427.
5. Golden MA, Hanson SR, Kirkman TR, Schneider PA, Clowes AW. Healing of polytetrafluoroethylene arterial grafts is influenced by graft porosity. J Vasc Surg 1990;11:838-844; discussion 845.
6. Cassell OC, Hofer SO, Morrison WA, Knight KR. Vascularisation of tissue-engineered grafts: the regulation of angiogenesis in reconstructive surgery and in disease states. Br J Plast Surg 2002;55:603-610.
7. Kidd KR, Nagle RB, Williams SK. Angiogenesis and neovascularization associated with extracellular matrix-modified porous implants. J Biomed Mater Res 2002;59:366-377.
8. Kidd KR, Patula VB, Williams SK. Accelerated endothelialization of interpositional 1-mm vascular grafts. J Surg Res 2003;113:234-242.
9. Ganta SR, Piesco NP, Long P, Gassner R, Motta LF, Papworth GD, Stolz DB, Watkins SC, Agarwal S. Vascularization and tissue infiltration of a biodegradable polyurethane matrix. J Biomed Mater Res 2003;64A:242-248.
10. Boswell CA, Williams SK. Denucleation promotes neovascularization of ePTFE in vivo. J Biomater Sci Polym Ed 1999;10:319-329.
11. Van Gelder RN, von Zastrow ME, Yool A, Dement WC, Barchas JD, Eberwine JH. Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci U S A 1990;87:1663-1667.
12. Kidd KR, Williams SK. Laminin-5-enriched extracellular matrix accelerates angiogenesis and neovascularization in association with ePTFE. J Biomed Mater Res 2004;69A:294-304.
13. Kerr MK, Martin M, Churchill GA. Analysis of variance for gene expression microarray data. J Comput Biol 2000;7:819-837.
14. Subramanian A, Miller DM. Structural analysis of alpha-enolase. Mapping the functional domains involved in down-regulation of the c-myc protooncogene. J Biol Chem 2000;275:5958-5965.
15. Saulot V, Vittecoq O, Charlionet R, Fardellone P, Lange C, Marvin L, Machour N, Le Loet X, Gilbert D, Tron F. Presence of autoantibodies to the glycolytic enzyme alpha-enolase in sera from patients with early rheumatoid arthritis. Arthritis Rheum 2002;46:1196-1201.
16. Lehman W, Hatch V, Korman V, Rosol M, Thomas L, Maytum R, Geeves MA, Van Eyk JE, Tobacman LS, Craig R. Tropomyosin and actin isoforms modulate the localization of tropomyosin strands on actin filaments. J Mol Biol 2000;302:593-606.
17. Naldini A, Carraro F. Hypoxia modulates cyclin and cytokine expression and inhibits peripheral mononuclear cell proliferation. J Cell Physiol 1999;181:448-454.
18. Ilan N, Madri JA. PECAM-1: old friend, new partners. Curr Opin Cell Biol 2003;15:515-524.
19. Kyriakides TR, Bornstein P. Matricellular proteins as modulators of wound healing and the foreign body response. Thromb Haemost 2003;90:986-992.
20. Sharkawy AA, Klitzman B, Truskey GA, Reichert WM. Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties. J Biomed Mater Res 1997;37:401-412.
21. Hagerty RD, Salzmann DL, Kleinert LB, Williams SK. Cellular proliferation and macrophage populations associated with implanted expanded polytetrafluoroethylene and polyethyleneterephthalate. J Biomed Mater Res 2000;49:489-497.
22. Ratner BD. Reducing capsular thickness and enhancing angiogenesis around implant drug release systems. J Control Release 2002;78:211-218.
23. Updike SJ, Shults MC, Gilligan BJ, Rhodes RK. A subcutaneous glucose sensor with improved longevity, dynamic range, and stability of calibration. Diabetes Care 2000;23:208-214.